Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Spruce Biosciences is a biopharmaceutical company developing therapies for neurological and rare diseases, including enzyme replacement and small molecule drugs. Its pipeline features treatments for MPS IIIB, depression, and congenital adrenal hyperplasia. The company focuses on targeted, biologic and small molecule therapeutics, leveraging strategic licensing, collaborations, and proprietary IP to address high unmet medical needs in niche markets worldwide.
This description was generated via AI from an annual report. Updated about 1 year ago.